Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04142138 · ClinicalTrials.gov registry record · NA
When the Kidney Reacts to Nutritional Changes
A NA study of Prehypertension, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT04142138: Completed NA study of Prehypertension, sponsored by Rockefeller University.
NCT04142138 is a NA study of Prehypertension that has completed, run by Rockefeller University. The registered enrollment target is 9 participants, below the 574-participant average among 13 other Prehypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04142138, a NA study of Prehypertension, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertension is one of the leading causes of morbidity and mortality in the industrialized world, attributed mostly to modifiable lifestyle factors. Aspects that are controlled by patients include physical activity, smoking, alcohol consumption, and nutrition. The DASH (Dietary Approach to Stop Hypertension) diet is a proven effective intervention in lowering blood pressure in multiple populations. In this proof of concept study, volunteers with untreated stage 1 hypertension, defined as mild high blood pressure with numbers in the range of 130 - 139 over 80 - 89, will receive a DASH-based menu during 5 days of hospitalization, during a weekend at home where they will continue the menu, another 5 days as inpatients, followed by a weekend at home on the same menu, and the return to the inpatient unit for an additional day for final testing. Throughout the intervention period, participants will be followed clinically and undergo repeated laboratory testing. The aim of this project is to characterize changes in urine electrolytes and exosome protein abundance pattern during nutritional changes, shifting from a "westernized diet" to a DASH diet.
Primary Outcome
Mass spectrometry generates a list of proteins for each sample. We will compare fold of change before (Day 1) and after intervention (Day 12) - a true change is defined as 1.5 fold.
Conditions Studied
Interventions
- OTHER DASH
Study Locations (1)
New York
- The Rockefeller University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-02-22 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
What the finished NCT04142138 record still lists
NCT04142138 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 574-participant average among 13 other Prehypertension trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Prehypertension appearing as the primary indexed condition, and to 1 intervention - of which DASH is the first listed.
NCT04142138 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04142138 about?
NCT04142138 is a clinical study titled "When the Kidney Reacts to Nutritional Changes". Hypertension is one of the leading causes of morbidity and mortality in the industrialized world, attributed mostly to modifiable lifestyle factors. Aspects that are controlled by patients include physical activity, smoking, alcohol consumption, and nutrition. The DASH (Dietary Approach to Stop Hype...
What is the current status of trial NCT04142138?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-02-22. Estimated completion is 2021-04-30.
What conditions does trial NCT04142138 study?
This clinical trial studies the following conditions: Prehypertension.
What interventions are being tested in trial NCT04142138?
The interventions under investigation include: DASH (OTHER).
Who is sponsoring clinical trial NCT04142138?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04142138 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prehypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04142138's enrollment target sits among peer trials
9 14th of 13 the lowest of 13 other Prehypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prehypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sympathetic Overactivity in Post-traumatic Stress Disorder
RECRUITING · NA
-
Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health
RECRUITING · NA
-
Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY
ACTIVE NOT RECRUITING · NA
-
HELP-HY: Health Education and sLeep Program in HYpertension
ACTIVE NOT RECRUITING · NA
-
Watermelon Dose Response Blood Pressure Study
ACTIVE NOT RECRUITING · NA
-
Macronutrient Effects on Alzheimer's Disease (MEAL-2)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI